Target-Driven Design of a Coumarinyl Chalcone Scaffold Based Novel EF2 Kinase Inhibitor Suppresses Breast Cancer Growth In Vivo (vol 4, pg 926, 2021)
Authors:
- Ferah Comert OnderFOFerah Comert Onder
- Nermin KahramanNKNermin Kahraman
- Esen Bellur AticiEAEsen Bellur Atici
- Ali CagirACAli Cagir
- Hakan KandemirHKHakan Kandemir
- Gizem TatarGTGizem Tatar
- Tugba Taskin TokTTTugba Taskin Tok
- Goknur KaraGKGoknur Kara
- Bekir KarligaBKBekir Karliga
- Serdar DurdagiSDSerdar Durdagi
- Mehmet AyMAMehmet Ay
- Bulent OzpolatBOBulent Ozpolat
- 4 May 2021
- journal article
- correction
- Published by American Chemical Society (ACS) in ACS Pharmacology & Translational Science
- Vol. 4 (3) , 1247
Abstract
No abstract availableFunding Information
- The Scientific and Technological Research Council of Turkey (TUBITAK) and NIH-NCI (1R01CA244344 grants, 215S008 and)